In ALS patients, IFN-γ has been found elevated in both CSF and blood compared to the levels measured in controls and OND, and have been associated with faster progression and shorter survival [47,60,67,77] (Table 3). This evidence concerns the gene IFNG and amyotrophic lateral sclerosis.